MedPath
TGA Approval

Doxorubicin Hydrochloride Injection 50 mg/25 mL (1) (285782)

285782

Doxorubicin Hydrochloride Injection 50 mg/25 mL (1)

Pfizer (Perth) Pty Ltd

February 16, 2017

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

doxorubicin hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Doxorubicin Hydrochloride Injection 50 mg/25 mL (1) (285782) - TGA 批准文号 | MedPath